These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 36769063)

  • 1. Exploring the Role of GMMA Components in the Immunogenicity of a 4-Valent Vaccine against
    Mancini F; Alfini R; Caradonna V; Monaci V; Carducci M; Gasperini G; Piccioli D; Biagini M; Giannelli C; Rossi O; Pizza M; Micoli F
    Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissecting the contribution of O-Antigen and proteins to the immunogenicity of Shigella sonnei generalized modules for membrane antigens (GMMA).
    Mancini F; Gasperini G; Rossi O; Aruta MG; Raso MM; Alfini R; Biagini M; Necchi F; Micoli F
    Sci Rep; 2021 Jan; 11(1):906. PubMed ID: 33441861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of
    Di Benedetto R; Mancini F; Caradonna V; Aruta MG; Giannelli C; Rossi O; Micoli F
    Front Mol Biosci; 2023; 10():1284515. PubMed ID: 38046812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement-mediated serum bactericidal activity of antibodies elicited by the
    Kapulu MC; Nakakana U; Sciré AS; Sarakinou E; Conti V; Rossi O; Acquaviva A; Necchi F; Obiero CW; Martin LB; Bejon P; Njuguna P; Micoli F; Podda A
    Front Immunol; 2022; 13():971866. PubMed ID: 36203568
    [No Abstract]   [Full Text] [Related]  

  • 5. Antibodies Elicited by the
    Micoli F; Rossi O; Conti V; Launay O; Sciré AS; Aruta MG; Nakakana UN; Marchetti E; Rappuoli R; Saul A; Martin LB; Necchi F; Podda A
    Front Immunol; 2021; 12():671325. PubMed ID: 34017343
    [No Abstract]   [Full Text] [Related]  

  • 6. Rationalizing the design of a broad coverage Shigella vaccine based on evaluation of immunological cross-reactivity among S. flexneri serotypes.
    Citiulo F; Necchi F; Mancini F; Rossi O; Aruta MG; Gasperini G; Alfini R; Rondini S; Micoli F; Rappuoli R; Saul A; Martin LB
    PLoS Negl Trop Dis; 2021 Oct; 15(10):e0009826. PubMed ID: 34644291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative proteomic analysis of Shigella flexneri and Shigella sonnei Generalized Modules for Membrane Antigens (GMMA) reveals highly pure preparations.
    Maggiore L; Yu L; Omasits U; Rossi O; Dougan G; Thomson NR; Saul A; Choudhary JS; Gerke C
    Int J Med Microbiol; 2016 Feb; 306(2):99-108. PubMed ID: 26746581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of a Shigella sonnei Vaccine Based on Generalized Modules for Membrane Antigens (GMMA), 1790GAHB.
    Gerke C; Colucci AM; Giannelli C; Sanzone S; Vitali CG; Sollai L; Rossi O; Martin LB; Auerbach J; Di Cioccio V; Saul A
    PLoS One; 2015; 10(8):e0134478. PubMed ID: 26248044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of O-Acetylation on
    Arato V; Oldrini D; Massai L; Gasperini G; Necchi F; Micoli F
    Microorganisms; 2021 Nov; 9(11):. PubMed ID: 34835485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A next-generation GMMA-based vaccine candidate to fight shigellosis.
    Rossi O; Citiulo F; Giannelli C; Cappelletti E; Gasperini G; Mancini F; Acquaviva A; Raso MM; Sollai L; Alfini R; Aruta MG; Vitali CG; Pizza M; Necchi F; Rappuoli R; Martin LB; Berlanda Scorza F; Colucci AM; Micoli F
    NPJ Vaccines; 2023 Sep; 8(1):130. PubMed ID: 37670042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of FAcE (Formulated Alhydrogel competitive ELISA) method for direct quantification of OAg present in Shigella sonnei GMMA-based vaccine and its optimization using Design of Experiments approach.
    Necchi F; Carducci M; Pisoni I; Rossi O; Saul A; Rondini S
    J Immunol Methods; 2019 Aug; 471():11-17. PubMed ID: 31039338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunization of Rabbits with a Quadrivalent
    Odundo EA; Weerts HP; Musila L; Ogonda L; Dreyer AM; Schneider J; Carranza P; Kaminski RW
    mSphere; 2022 Jun; 7(3):e0102021. PubMed ID: 35611657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Phase 2a Randomized Study to Evaluate the Safety and Immunogenicity of the 1790GAHB Generalized Modules for Membrane Antigen Vaccine against
    Obiero CW; Ndiaye AGW; Sciré AS; Kaunyangi BM; Marchetti E; Gone AM; Schütte LD; Riccucci D; Auerbach J; Saul A; Martin LB; Bejon P; Njuguna P; Podda A
    Front Immunol; 2017; 8():1884. PubMed ID: 29375556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outer Membrane Vesicles Derived from
    Tian H; Li B; Xu T; Yu H; Chen J; Yu H; Li S; Zeng L; Huang X; Liu Q
    Appl Environ Microbiol; 2021 Sep; 87(19):e0096821. PubMed ID: 34319809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From an in vivo to an in vitro relative potency (IVRP) assay to fully characterize a multicomponent O-antigen based vaccine against Shigella.
    Necchi F; Giannelli C; Acquaviva A; Alfini R; Monaci V; Arato V; Rossi O; Micoli F
    Carbohydr Polym; 2023 Aug; 314():120920. PubMed ID: 37173008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Towards a Four-Component GMMA-Based Vaccine against
    Micoli F; Nakakana UN; Berlanda Scorza F
    Vaccines (Basel); 2022 Feb; 10(2):. PubMed ID: 35214786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Signature of Monocytes Shaped by the
    Tondi S; Siena E; Essaghir A; Bozzetti B; Bechtold V; Scaillet A; Clemente B; Marrocco M; Sammicheli C; Tavarini S; Micoli F; Oldrini D; Pezzicoli A; Di Fede M; Brazzoli M; Ulivieri C; Schiavetti F
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GMMA and Glycoconjugate Approaches Compared in Mice for the Development of a Vaccine against
    Raso MM; Gasperini G; Alfini R; Schiavo F; Aruta MG; Carducci M; Forgione MC; Martini S; Cescutti P; Necchi F; Micoli F
    Vaccines (Basel); 2020 Apr; 8(2):. PubMed ID: 32260067
    [No Abstract]   [Full Text] [Related]  

  • 19. Stable Chromosomal Expression of Shigella flexneri 2a and 3a O-Antigens in the Live Salmonella Oral Vaccine Vector Ty21a.
    Dharmasena MN; Osorio M; Takeda K; Stibitz S; Kopecko DJ
    Clin Vaccine Immunol; 2017 Dec; 24(12):. PubMed ID: 29046309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety Profile and Immunologic Responses of a Novel Vaccine Against Shigella sonnei Administered Intramuscularly, Intradermally and Intranasally: Results From Two Parallel Randomized Phase 1 Clinical Studies in Healthy Adult Volunteers in Europe.
    Launay O; Lewis DJM; Anemona A; Loulergue P; Leahy J; Sciré AS; Maugard A; Marchetti E; Zancan S; Huo Z; Rondini S; Marhaba R; Finco O; Martin LB; Auerbach J; Cohen D; Saul A; Gerke C; Podda A
    EBioMedicine; 2017 Aug; 22():164-172. PubMed ID: 28735965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.